PMS43 COST-UTILITY AND MULTINOMIAL EXPECTED VALUE OF PERFECT INFORMATION OF SEQUENCED TREATMENT WITH BIOLOGICS IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS- ANALYSIS BASED ON CLINICALLY MEANINGFUL RESPONSES

Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72196-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72196-9/fulltext
Section Title : RESEARCH POSTER ABSTRACTS
Section Order : 354
First Page : A310
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72196-9&doi=10.1016/S1098-3015(11)72196-9
HEOR Topics :
Tags :
Regions :